Company: FEAV
Filing Date: 2025-08-25
Form Type: 424B5
Source: 0001888654-25-000019
Chunk: 19

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-08-25
Form: 424B5
Chunk 19
---
 the underwriters that they propose to offer the shares of common stock directly to the public at the public offering price set forth on the cover page of this prospectus supplement. Any shares of common stock sold by the underwriters to securities dealers will be sold at the public offering price. The underwriting agreement provides that the underwriters’ obligation to purchase the shares of common stock we are offering is subject to conditions contained in the underwriting agreement. No action has been taken by us or the underwriters that would permit a public offering of the shares of common stock in any jurisdiction outside the United States where action for that purpose is required. None of our shares of common stock included in this offering may be offered or sold, directly or indirectly, nor may this prospectus supplement or any other offering material or advertisements in connection with the offer and sales of any of the shares of common stock offered hereby be distributed or published in any jurisdiction except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons who receive this prospectus supplement are advised to inform themselves about and to observe any restrictions relating to this offering of shares of common stock and the distribution of this prospectus supplement. This prospectus supplement is neither an offer to sell nor a solicitation of any offer to buy the shares of common stock in any jurisdiction where that would not be permitted or legal. The underwriters have advised us that they do not intend to confirm sales to any account over which they exercise discretionary authority. Bluescape and Ascend have, severally and not jointly, each indicated an interest in purchasing (directly or through related entities) approximately $350,000 in shares of common stock in this offering at the public offering price. Any shares of common stock to be purchased by Bluescape and Ascend in this offering will not be subject to a lock-up agreement with the underwriter. Because indications of interest are not a binding agreement or commitment to purchase, either Bluescape and Ascend may determine to purchase more, less or no shares in this offering or the underwriter may determine to sell more, less or no shares to Bluescape and Ascend.

<div align='center'>S-11</div>

Underwriting Discount and Expenses The following table summarizes the underwriting discount and commission to be paid to the underwriters by us.

|                                         |     | Per Share(1) |     |       |     | Total |     |              |
|:----------------------------------------|:----|:-------------|:----|------:|:----|:------|: